LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Phase 3 Completed 600 enrolled Bausch & Lomb Incorporated

RandomizedParallel-groupTriple-blindTreatment

Summary

Loteprednol Etabonate Ophthalmic Gel, (BID and TID) versus Vehicle Group for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery.

Timeline

Start: 2016-06
Primary completion: 2017-06-13
Completion: 2017-07-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Loteprednol Etabonate	Other / unclassified	—	—

LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Summary

Timeline

Drugs

Indications